Racer Pharma Private Limited
Founded in 2012 and headquartered in Uttar Pradesh, India.
2012 | Bahraich, Uttar Pradesh (India) | Active
Racer Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.78 M
About Racer Pharma
Racer Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2012 and has a history of 12 years and eight months. Its registered office is in Bahraich, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.78 M.
Mohd Khan and Izhar Ali serve as directors at the Company.
Company Details
- Location
Bahraich, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233UP2012PTC051005
- Company No.
051005
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Pharma
What products or services does Racer Pharma Private Limited offer?
Racer Pharma Private Limited offers a wide range of products and services, including Antifungal Cream, Ointment & Powder, Luliconazole Cream.
Who are the key members and board of directors at Racer Pharma?
Board Members (2)
Financial Performance of Racer Pharma.
Racer Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Racer Pharma?
In 2017, Racer Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹1.78 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 May 2016 | Bank Of India | ₹1.78 M | Open |
How Many Employees Work at Racer Pharma?
Unlock and access historical data on people associated with Racer Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Racer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Racer Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.